Wondering if Fisher & Paykel Healthcare at around NZ$35.80 is offering good value right now, or if the share price already reflects the story you are buying into? The stock is showing mixed returns, ...

Industrial services gained the most among New Zealand sectors on Tuesday, advancing nearly 1%. Ventia Services Group's ...

After Wall Street pulled back from record highs overnight and global growth stocks came under pressure, the NZX 50 looks set for a softer open this morning. One of the biggest overnight moves came ...

New Zealand’s S&P/NZX 50 index joined the ASX lower as the Australian federal government’s plans to make housing more ...

NZX 20 futures finished up 0.1% yesterday, suggesting a modestly firmer open, although higher oil prices and rising ...

New Zealand’s S&P/NZX 50 index climbed for a second day, again powered by Infratil as the infrastructure investor’s major new ...

Sector under pressure: ASX healthcare shares have fallen sharply in 2026, with the sector index at an 8-year low due to cost pressures, currency impacts, and tariff risks. Investors spot value: ...

A Truth Social post led to a boost in the price of oil and a drop in Australia’s sharemarket, as a healthcare heavyweight hit ...

Equities strategists at UBS have told clients that Tuesday’s budget will be the most consequential for the sharemarket in ...

Find insight on Novo Nordisk, GSK, Smith & Nephew and more in the latest Market Talks covering Health Care.

The global Anti-snoring Devices Market size is projected to grow at a CAGR of 8% over the next five years. The increasing ...